A New Era for Edesa Biotech’s Financial Leadership as Peter J. Weiler Takes the Helm
Peter J. Weiler appointed as new Chief Financial Officer of Edesa Biotech, effective May 1, 2025. Weiler brings extensive experience from his previous roles at Exzell Pharma, Biosyent Inc., and…
Biotech Shuffle: What Edesa Biotech’s New CFO Appointment Means for Its Future
Edesa Biotech announces a pivotal leadership transition with Peter J. Weiler taking over as Chief Financial Officer on May 1, 2025. Weiler brings extensive experience from previous roles at Exzell…
Why Edesa Biotech’s Leadership Shakeup May Transform Its Financial Future
Edesa Biotech appoints Peter J. Weiler as Chief Financial Officer, effective May 1, 2025, signaling a strategic shift in leadership. Weiler brings over a decade of experience in biotechnology and…
The Strategic Shift: Edesa Biotech’s New CFO Brings Fresh Momentum
Edesa Biotech welcomes Peter J. Weiler as the new financial leader, effective May 1, 2025, to invigorate the company's strategic ambitions. Weiler's robust background includes roles at Exzell Pharma, Cipher…
The Unexpected Power Move at Edesa: A Leader from the Shadows
Edesa Biotech appoints Peter J. Weiler as Chief Financial Officer effective May 1, 2025, succeeding Stephen Lemieux. Weiler brings extensive experience from his leadership role at Exzell Pharma and holds…
Can a New CFO Transform Edesa Biotech’s Fortune?
Edesa Biotech appoints Peter J. Weiler as Chief Financial Officer starting May 1, 2025, to enhance drug development efforts for immuno-inflammatory diseases. Weiler brings extensive pharmaceutical experience, previously holding key…
Biotech Leadership Shift: How Edesa’s New CFO Could Shape the Future
Edesa Biotech announces Peter J. Weiler as its incoming Chief Financial Officer, effective May 1, 2025. Weiler transitions from his role as President of Exzell Pharma, bringing strategic expertise in…
The Strategic Shift at Edesa Biotech: A New Financial Navigator Takes the Helm
Edesa Biotech announces a leadership change, appointing Peter J. Weiler as Chief Financial Officer, effective May 1, 2025. Weiler's strategic and industry expertise, bolstered by roles at Exzell Pharma and…
Meet the New Financial Maestro Behind Edesa Biotech’s Strategic Evolution
Edesa Biotech announces Peter J. Weiler as the new CFO, signifying a strategic leadership shift. Weiler brings extensive experience in finance, biology, and business from his roles at Exzell Pharma,…
The Bold New Financial Move at Edesa Biotech: What It Means for the Future
Edesa Biotech has announced a strategic leadership change, appointing Peter J. Weiler as Chief Financial Officer effective May 1, 2025. Weiler brings extensive experience from roles at Exzell Pharma, Biosyent…